 | • レポートコード：20QY06-06476 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、樹状細胞および腫瘍細胞がんワクチンのグローバル市場について種類別（CD 4、CD 8、HER-2、T-ヘルパー細胞、その他）、用途別（膠芽腫がん、前立腺がん、膵がん、結腸直腸がん、腎がん、肺がん、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・樹状細胞および腫瘍細胞がんワクチン市場の概要 ・世界の主要地域別樹状細胞および腫瘍細胞がんワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の樹状細胞および腫瘍細胞がんワクチン市場規模2015-2026：種類別（CD 4、CD 8、HER-2、T-ヘルパー細胞、その他） ・世界の樹状細胞および腫瘍細胞がんワクチン市場規模2015-2026：用途別（膠芽腫がん、前立腺がん、膵がん、結腸直腸がん、腎がん、肺がん、その他） ・樹状細胞および腫瘍細胞がんワクチンの北米市場規模2015-2020 ・樹状細胞および腫瘍細胞がんワクチンのヨーロッパ市場規模2015-2020 ・樹状細胞および腫瘍細胞がんワクチンの中国市場規模2015-2020 ・樹状細胞および腫瘍細胞がんワクチンの日本市場規模2015-2020 ・樹状細胞および腫瘍細胞がんワクチンの東南アジア市場規模2015-2020 ・樹状細胞および腫瘍細胞がんワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （JW CreaGene、Miltenyi Biotec、GlaxoSmithKline、NorthWest BioTherapeutics、ImmunoCellular Therapeutics、EnoChian Bioscience、Medigene、Tella Incorporation） ・樹状細胞および腫瘍細胞がんワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・樹状細胞および腫瘍細胞がんワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Dendritic Cell and Tumor Cell Cancer Vaccine market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Dendritic cells (part of neuron) plays an important role in inducing anti-tumor activity. Hence, various strategies are being developed to treat cancer with the help of dendritic cell.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Dendritic Cell and Tumor Cell Cancer Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Dendritic Cell and Tumor Cell Cancer Vaccine industry.
Based on our recent survey, we have several different scenarios about the Dendritic Cell and Tumor Cell Cancer Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Dendritic Cell and Tumor Cell Cancer Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Dendritic Cell and Tumor Cell Cancer Vaccine market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Dendritic Cell and Tumor Cell Cancer Vaccine market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Dendritic Cell and Tumor Cell Cancer Vaccine market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Dendritic Cell and Tumor Cell Cancer Vaccine market. The report also includes nautical information, where it shows Dendritic Cell and Tumor Cell Cancer Vaccine market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Dendritic Cell and Tumor Cell Cancer Vaccine market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Dendritic Cell and Tumor Cell Cancer Vaccine market.
Geographical Analysis:
Based on region, the global Dendritic Cell and Tumor Cell Cancer Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Dendritic Cell and Tumor Cell Cancer Vaccine market are
JW CreaGene
Miltenyi Biotec
GlaxoSmithKline
NorthWest BioTherapeutics
ImmunoCellular Therapeutics
EnoChian Bioscience
Medigene
Tella Incorporation
Segment by Type
CD 4
CD 8
HER-2
T-helper cell
Others
Segment by Application
Glioblastoma Cancer
Prostate Cancer
Pancreatic Cancer
Colorectal Cancer
Renal Cancer
Lung Cancer
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Dendritic Cell and Tumor Cell Cancer Vaccine market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Dendritic Cell and Tumor Cell Cancer Vaccine market.
• The market share of the global Dendritic Cell and Tumor Cell Cancer Vaccine market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Dendritic Cell and Tumor Cell Cancer Vaccine market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Dendritic Cell and Tumor Cell Cancer Vaccine market.
1 Dendritic Cell and Tumor Cell Cancer Vaccine Market Overview
1.1 Dendritic Cell and Tumor Cell Cancer Vaccine Product Scope
1.2 Dendritic Cell and Tumor Cell Cancer Vaccine Segment by Type
1.2.1 Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales by Type (2020-2026)
1.2.2 CD 4
1.2.3 CD 8
1.2.4 HER-2
1.2.5 T-helper cell
1.2.6 Others
1.3 Dendritic Cell and Tumor Cell Cancer Vaccine Segment by Application
1.3.1 Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Glioblastoma Cancer
1.3.3 Prostate Cancer
1.3.4 Pancreatic Cancer
1.3.5 Colorectal Cancer
1.3.6 Renal Cancer
1.3.7 Lung Cancer
1.3.8 Others
1.4 Dendritic Cell and Tumor Cell Cancer Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Dendritic Cell and Tumor Cell Cancer Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Dendritic Cell and Tumor Cell Cancer Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Dendritic Cell and Tumor Cell Cancer Vaccine Industry
1.5.1.1 Dendritic Cell and Tumor Cell Cancer Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Dendritic Cell and Tumor Cell Cancer Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Dendritic Cell and Tumor Cell Cancer Vaccine Players to Combat Covid-19 Impact
2 Dendritic Cell and Tumor Cell Cancer Vaccine Estimate and Forecast by Region
2.1 Global Dendritic Cell and Tumor Cell Cancer Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Dendritic Cell and Tumor Cell Cancer Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Dendritic Cell and Tumor Cell Cancer Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Dendritic Cell and Tumor Cell Cancer Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Dendritic Cell and Tumor Cell Cancer Vaccine Estimates and Projections (2015-2026)
2.4.3 China Dendritic Cell and Tumor Cell Cancer Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Dendritic Cell and Tumor Cell Cancer Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Dendritic Cell and Tumor Cell Cancer Vaccine Estimates and Projections (2015-2026)
2.4.6 India Dendritic Cell and Tumor Cell Cancer Vaccine Estimates and Projections (2015-2026)
3 Global Dendritic Cell and Tumor Cell Cancer Vaccine Competition Landscape by Players
3.1 Global Top Dendritic Cell and Tumor Cell Cancer Vaccine Players by Sales (2015-2020)
3.2 Global Top Dendritic Cell and Tumor Cell Cancer Vaccine Players by Revenue (2015-2020)
3.3 Global Dendritic Cell and Tumor Cell Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dendritic Cell and Tumor Cell Cancer Vaccine as of 2019)
3.4 Global Dendritic Cell and Tumor Cell Cancer Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Dendritic Cell and Tumor Cell Cancer Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Dendritic Cell and Tumor Cell Cancer Vaccine Players (Opinion Leaders)
4 Global Dendritic Cell and Tumor Cell Cancer Vaccine Market Size by Type
4.1 Global Dendritic Cell and Tumor Cell Cancer Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Dendritic Cell and Tumor Cell Cancer Vaccine Price by Type (2014-2020)
4.2 Global Dendritic Cell and Tumor Cell Cancer Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Dendritic Cell and Tumor Cell Cancer Vaccine Price Forecast by Type (2021-2026)
5 Global Dendritic Cell and Tumor Cell Cancer Vaccine Market Size by Application
5.1 Global Dendritic Cell and Tumor Cell Cancer Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Dendritic Cell and Tumor Cell Cancer Vaccine Price by Application (2015-2020)
5.2 Global Dendritic Cell and Tumor Cell Cancer Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Dendritic Cell and Tumor Cell Cancer Vaccine Price Forecast by Application (2021-2026)
3 North America Dendritic Cell and Tumor Cell Cancer Vaccine Market Facts & Figures
3.2 North America Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
4 Europe Dendritic Cell and Tumor Cell Cancer Vaccine Market Facts & Figures
4.2 Europe Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
5 China Dendritic Cell and Tumor Cell Cancer Vaccine Market Facts & Figures
5.2 China Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company (2015-2020)
5.3 China Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
5.4 China Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
6 Japan Dendritic Cell and Tumor Cell Cancer Vaccine Market Facts & Figures
6.2 Japan Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Dendritic Cell and Tumor Cell Cancer Vaccine Market Facts & Figures
7.2 Southeast Asia Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
8 India Dendritic Cell and Tumor Cell Cancer Vaccine Market Facts & Figures
8.2 India Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company (2015-2020)
8.3 India Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
8.4 India Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Dendritic Cell and Tumor Cell Cancer Vaccine Business
12.1 JW CreaGene
12.1.1 JW CreaGene Dendritic Cell and Tumor Cell Cancer Vaccine Corporation Information
12.1.2 JW CreaGene Dendritic Cell and Tumor Cell Cancer Vaccine Business Overview and Total Revenue
12.1.3 JW CreaGene Dendritic Cell and Tumor Cell Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 JW CreaGene Dendritic Cell and Tumor Cell Cancer Vaccine Products Offered
12.1.5 JW CreaGene Recent Development
12.2 Miltenyi Biotec
12.2.1 Miltenyi Biotec Dendritic Cell and Tumor Cell Cancer Vaccine Corporation Information
12.2.2 Miltenyi Biotec Dendritic Cell and Tumor Cell Cancer Vaccine Business Overview and Total Revenue
12.2.3 Miltenyi Biotec Dendritic Cell and Tumor Cell Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Miltenyi Biotec Dendritic Cell and Tumor Cell Cancer Vaccine Products Offered
12.2.5 Miltenyi Biotec Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Dendritic Cell and Tumor Cell Cancer Vaccine Corporation Information
12.3.2 GlaxoSmithKline Dendritic Cell and Tumor Cell Cancer Vaccine Business Overview and Total Revenue
12.3.3 GlaxoSmithKline Dendritic Cell and Tumor Cell Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GlaxoSmithKline Dendritic Cell and Tumor Cell Cancer Vaccine Products Offered
12.3.5 GlaxoSmithKline Recent Development
12.4 NorthWest BioTherapeutics
12.4.1 NorthWest BioTherapeutics Dendritic Cell and Tumor Cell Cancer Vaccine Corporation Information
12.4.2 NorthWest BioTherapeutics Dendritic Cell and Tumor Cell Cancer Vaccine Business Overview and Total Revenue
12.4.3 NorthWest BioTherapeutics Dendritic Cell and Tumor Cell Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 NorthWest BioTherapeutics Dendritic Cell and Tumor Cell Cancer Vaccine Products Offered
12.4.5 NorthWest BioTherapeutics Recent Development
12.5 ImmunoCellular Therapeutics
12.5.1 ImmunoCellular Therapeutics Dendritic Cell and Tumor Cell Cancer Vaccine Corporation Information
12.5.2 ImmunoCellular Therapeutics Dendritic Cell and Tumor Cell Cancer Vaccine Business Overview and Total Revenue
12.5.3 ImmunoCellular Therapeutics Dendritic Cell and Tumor Cell Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 ImmunoCellular Therapeutics Dendritic Cell and Tumor Cell Cancer Vaccine Products Offered
12.5.5 ImmunoCellular Therapeutics Recent Development
12.6 EnoChian Bioscience
12.6.1 EnoChian Bioscience Dendritic Cell and Tumor Cell Cancer Vaccine Corporation Information
12.6.2 EnoChian Bioscience Dendritic Cell and Tumor Cell Cancer Vaccine Business Overview and Total Revenue
12.6.3 EnoChian Bioscience Dendritic Cell and Tumor Cell Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 EnoChian Bioscience Dendritic Cell and Tumor Cell Cancer Vaccine Products Offered
12.6.5 EnoChian Bioscience Recent Development
12.7 Medigene
12.7.1 Medigene Dendritic Cell and Tumor Cell Cancer Vaccine Corporation Information
12.7.2 Medigene Dendritic Cell and Tumor Cell Cancer Vaccine Business Overview and Total Revenue
12.7.3 Medigene Dendritic Cell and Tumor Cell Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Medigene Dendritic Cell and Tumor Cell Cancer Vaccine Products Offered
12.7.5 Medigene Recent Development
12.8 Tella Incorporation
12.8.1 Tella Incorporation Dendritic Cell and Tumor Cell Cancer Vaccine Corporation Information
12.8.2 Tella Incorporation Dendritic Cell and Tumor Cell Cancer Vaccine Business Overview and Total Revenue
12.8.3 Tella Incorporation Dendritic Cell and Tumor Cell Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Tella Incorporation Dendritic Cell and Tumor Cell Cancer Vaccine Products Offered
12.8.5 Tella Incorporation Recent Development
13 Dendritic Cell and Tumor Cell Cancer Vaccine Manufacturing Cost Analysis
13.1 Dendritic Cell and Tumor Cell Cancer Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Dendritic Cell and Tumor Cell Cancer Vaccine
13.4 Dendritic Cell and Tumor Cell Cancer Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Dendritic Cell and Tumor Cell Cancer Vaccine Distributors List
14.3 Dendritic Cell and Tumor Cell Cancer Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Dendritic Cell and Tumor Cell Cancer Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Dendritic Cell and Tumor Cell Cancer Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Dendritic Cell and Tumor Cell Cancer Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Dendritic Cell and Tumor Cell Cancer Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Region (2015-2020)
Table 10. Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Dendritic Cell and Tumor Cell Cancer Vaccine (K Units) of Key Companies (2015-2020)
Table 18. Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Share by Company (2015-2020)
Table 19. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Dendritic Cell and Tumor Cell Cancer Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dendritic Cell and Tumor Cell Cancer Vaccine as of 2019)
Table 22. Global Dendritic Cell and Tumor Cell Cancer Vaccine Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Dendritic Cell and Tumor Cell Cancer Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Dendritic Cell and Tumor Cell Cancer Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Dendritic Cell and Tumor Cell Cancer Vaccine Players
Table 27. Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Type (2015-2020)
Table 28. Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Share by Type (2015-2020)
Table 29. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Dendritic Cell and Tumor Cell Cancer Vaccine Price (K Units) by Type (2015-2020)
Table 31. Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Share by Type (2021-2026)
Table 32. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Dendritic Cell and Tumor Cell Cancer Vaccine Price (K Units) by Type (2021-2026)
Table 35. Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Application (2015-2020)
Table 36. Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Share by Application (2015-2020)
Table 37. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Dendritic Cell and Tumor Cell Cancer Vaccine Price (K Units) by Application (2015-2020)
Table 39. Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Application (2021-2026)
Table 40. Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Share by Application (2021-2026)
Table 41. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Dendritic Cell and Tumor Cell Cancer Vaccine Price (K Units) by Application (2021-2026)
Table 44. United States Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Company (2015-2020)
Table 45. United States Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Type (2015-2020)
Table 47. United States Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Application (2015-2020)
Table 49. United States Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Company (2015-2020)
Table 51. Europe Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Type (2015-2020)
Table 53. Europe Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Application (2015-2020)
Table 55. Europe Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Company (2015-2020)
Table 57. China Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Type (2015-2020)
Table 59. China Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Application (2015-2020)
Table 61. China Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Company (2015-2020)
Table 63. Japan Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Type (2015-2020)
Table 65. Japan Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Application (2015-2020)
Table 67. Japan Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Company (2015-2020)
Table 75. India Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Type (2015-2020)
Table 77. India Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) by Application (2015-2020)
Table 79. India Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
Table 80. JW CreaGene Corporation Information
Table 81. JW CreaGene Description and Business Overview
Table 82. JW CreaGene Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. JW CreaGene Dendritic Cell and Tumor Cell Cancer Vaccine Product
Table 84. JW CreaGene Recent Development
Table 85. Miltenyi Biotec Corporation Information
Table 86. Miltenyi Biotec Description and Business Overview
Table 87. Miltenyi Biotec Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Miltenyi Biotec Dendritic Cell and Tumor Cell Cancer Vaccine Product
Table 89. Miltenyi Biotec Recent Development
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. GlaxoSmithKline Dendritic Cell and Tumor Cell Cancer Vaccine Product
Table 94. GlaxoSmithKline Recent Development
Table 95. NorthWest BioTherapeutics Corporation Information
Table 96. NorthWest BioTherapeutics Description and Business Overview
Table 97. NorthWest BioTherapeutics Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. NorthWest BioTherapeutics Dendritic Cell and Tumor Cell Cancer Vaccine Product
Table 99. NorthWest BioTherapeutics Recent Development
Table 100. ImmunoCellular Therapeutics Corporation Information
Table 101. ImmunoCellular Therapeutics Description and Business Overview
Table 102. ImmunoCellular Therapeutics Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. ImmunoCellular Therapeutics Dendritic Cell and Tumor Cell Cancer Vaccine Product
Table 104. ImmunoCellular Therapeutics Recent Development
Table 105. EnoChian Bioscience Corporation Information
Table 106. EnoChian Bioscience Description and Business Overview
Table 107. EnoChian Bioscience Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. EnoChian Bioscience Dendritic Cell and Tumor Cell Cancer Vaccine Product
Table 109. EnoChian Bioscience Recent Development
Table 110. Medigene Corporation Information
Table 111. Medigene Description and Business Overview
Table 112. Medigene Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Medigene Dendritic Cell and Tumor Cell Cancer Vaccine Product
Table 114. Medigene Recent Development
Table . Tella Incorporation Corporation Information
Table . Tella Incorporation Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Tella Incorporation Description and Business Overview
Table . Tella Incorporation Dendritic Cell and Tumor Cell Cancer Vaccine Product
Table . Tella Incorporation Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Dendritic Cell and Tumor Cell Cancer Vaccine Distributors List
Table 123. Dendritic Cell and Tumor Cell Cancer Vaccine Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Dendritic Cell and Tumor Cell Cancer Vaccine Product Picture
Figure 2. Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Dendritic Cell and Tumor Cell Cancer Vaccine Market Share by Application in 2020 & 2026
Figure 6. Glioblastoma Cancer Examples
Figure 7. Prostate Cancer Examples
Figure 8. Pancreatic Cancer Examples
Figure 9. Colorectal Cancer Examples
Figure 10. Renal Cancer Examples
Figure 11. Lung Cancer Examples
Figure 12. Others Examples
Figure 13. Global Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) Growth Rate (2015-2026)
Figure 14. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 15. Global Dendritic Cell and Tumor Cell Cancer Vaccine Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 16. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 17. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 18. United States Dendritic Cell and Tumor Cell Cancer Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. United States Dendritic Cell and Tumor Cell Cancer Vaccine Sales (K Units) Growth Rate (2015-2026)
Figure 20. Europe Dendritic Cell and Tumor Cell Cancer Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Europe Dendritic Cell and Tumor Cell Cancer Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. China Dendritic Cell and Tumor Cell Cancer Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. China Dendritic Cell and Tumor Cell Cancer Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 24. Japan Dendritic Cell and Tumor Cell Cancer Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Japan Dendritic Cell and Tumor Cell Cancer Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Southeast Asia Dendritic Cell and Tumor Cell Cancer Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. Southeast Asia Dendritic Cell and Tumor Cell Cancer Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 28. India Dendritic Cell and Tumor Cell Cancer Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 29. India Dendritic Cell and Tumor Cell Cancer Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 30. Global 5 Largest Dendritic Cell and Tumor Cell Cancer Vaccine Players Market Share by Revenue in Dendritic Cell and Tumor Cell Cancer Vaccine 2015 & 2019
Figure 31. Dendritic Cell and Tumor Cell Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 32. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Share by Type (2015-2020)
Figure 33. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 34. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Share by Application (2015-2020)
Figure 35. Global Dendritic Cell and Tumor Cell Cancer Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 36. United States Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type in 2019
Figure 37. United States Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type in 2019
Figure 38. Europe Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company in 2019
Figure 39. Europe Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type in 2019
Figure 40. Europe Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application in 2019
Figure 41. China Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company in 2019
Figure 42. China Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type in 2019
Figure 43. China Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application in 2019
Figure 44. Japan Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company in 2019
Figure 45. Japan Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type in 2019
Figure 46. Japan Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application in 2019
Figure 47. Southeast Asia Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company in 2019
Figure 48. Southeast Asia Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type in 2019
Figure 49. Southeast Asia Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application in 2019
Figure 50. India Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Company in 2019
Figure 51. India Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Type in 2019
Figure 52. India Dendritic Cell and Tumor Cell Cancer Vaccine Sales Market Share by Application in 2019
Figure 53. JW CreaGene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Miltenyi Biotec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. NorthWest BioTherapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. ImmunoCellular Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. EnoChian Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Medigene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Tella Incorporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of Dendritic Cell and Tumor Cell Cancer Vaccine
Figure 63. Manufacturing Process Analysis of Dendritic Cell and Tumor Cell Cancer Vaccine
Figure 64. Dendritic Cell and Tumor Cell Cancer Vaccine Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
樹状細胞がんワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dendritic Cell Cancer Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dendritic Cell …- 移行上皮がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Transitional Cell Cancer Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Transit…
- 骨髄性白血病細胞分化誘導タンパク質Mcl-1の世界市場レポート2020 Market Analysis and Insights: Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market The global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during…
- mRNAワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global mRNA Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The mRNA Vaccine market report provi…
- 癌ペプチドワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Peptide Cancer Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accu…